Literature DB >> 23532211

Do multiple nuclear factor kappa B activation mechanisms explain its varied effects in the heart?

Rajesh Kumar1, Qian Chen Yong, Candice M Thomas.   

Abstract

BACKGROUND: Multiple studies have demonstrated the important role of the nuclear factor kappa B (NF-κB) in cardiac pathology. However, these studies' conclusions differ regarding whether NF-κB is protective or detrimental for heart function. This disagreement is not surprising considering the complexity of NF-κB signaling that involves multiple components and regulation at several steps. Furthermore, NF-κB is a pleiotropic transcription factor that receives signals from multiple pathways, including the renin-angiotensin system (RAS) and cytokines, 2 important modulators of cardiac remodeling.
METHODS: In this article, we review studies related to the role and mechanisms of NF-κB activation in the heart, particularly with regard to the RAS, inflammation, and diabetes. The objective of this review is to consolidate multiple, often contradictory, findings to develop a clear understanding of NF-κB signaling in the heart.
CONCLUSIONS: The studies we review demonstrate that NF-κB effects in the heart are mechanism specific and that NF-κB signaling is cyclical. Consequently, the timing of NF-κB measurement is critical, and studies focused on temporal changes in the NF-κB mechanism would help clarify its multiple roles in cardiac pathophysiology.

Entities:  

Keywords:  Cytokines; NF-kappa B; diabetes mellitus; heart; renin-angiotensin system

Year:  2013        PMID: 23532211      PMCID: PMC3603179     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  61 in total

Review 1.  The intracrine renin-angiotensin system.

Authors:  Rajesh Kumar; Candice M Thomas; Qian Chen Yong; Wen Chen; Kenneth M Baker
Journal:  Clin Sci (Lond)       Date:  2012-09       Impact factor: 6.124

2.  Involvement of nuclear factor κB (NF-κB) signaling pathway in regulation of cardiac G protein-coupled receptor kinase 5 (GRK5) expression.

Authors:  Kazi N Islam; Walter J Koch
Journal:  J Biol Chem       Date:  2012-03-02       Impact factor: 5.157

3.  Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition.

Authors:  L X Zhang; Y Zhao; G Cheng; T L Guo; Y E Chin; P Y Liu; T C Zhao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

4.  Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression.

Authors:  Artavazd Tadevosyan; Ange Maguy; Louis R Villeneuve; Judith Babin; Arnaud Bonnefoy; Bruce G Allen; Stanley Nattel
Journal:  J Biol Chem       Date:  2010-05-12       Impact factor: 5.157

5.  Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure.

Authors:  Tariq Hamid; Shang Z Guo; Justin R Kingery; Xilin Xiang; Buddhadeb Dawn; Sumanth D Prabhu
Journal:  Cardiovasc Res       Date:  2010-08-25       Impact factor: 10.787

6.  Cardiac-specific blockade of NF-kappaB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo.

Authors:  Maria Brown; Michael McGuinness; Terry Wright; Xiaoping Ren; Yang Wang; Gregory P Boivin; Harvey Hahn; Arthur M Feldman; W Keith Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-02-04       Impact factor: 4.733

7.  Nuclear Factor (NF) kappaB polymorphism is associated with heart function in patients with heart failure.

Authors:  Diogo G B Santos; Marina F Resende; José G Mill; Alfredo J Mansur; José E Krieger; Alexandre C Pereira
Journal:  BMC Med Genet       Date:  2010-06-09       Impact factor: 2.103

8.  Blockade of NF-kappaB using IkappaB alpha dominant-negative mice ameliorates cardiac hypertrophy in myotrophin-overexpressed transgenic mice.

Authors:  David Young; Zoran B Popovic; W Keith Jones; Sudhiranjan Gupta
Journal:  J Mol Biol       Date:  2008-06-05       Impact factor: 5.469

Review 9.  Diabetic cardiomyopathy revisited.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

10.  Superoxide scavenging and Akt inhibition in myocardium ameliorate pressure overload-induced NF-κB activation and cardiac hypertrophy.

Authors:  Shawn D Hingtgen; Zhenbo Li; William Kutschke; Xin Tian; Ram V Sharma; Robin L Davisson
Journal:  Physiol Genomics       Date:  2010-01-26       Impact factor: 3.107

View more
  10 in total

1.  Interleukin-10 Deficiency Alters Endothelial Progenitor Cell-Derived Exosome Reparative Effect on Myocardial Repair via Integrin-Linked Kinase Enrichment.

Authors:  Yujia Yue; Chunlin Wang; Cindy Benedict; Grace Huang; May Truongcao; Rajika Roy; Maria Cimini; Venkata Naga Srikanth Garikipati; Zhongjian Cheng; Walter J Koch; Raj Kishore
Journal:  Circ Res       Date:  2019-12-09       Impact factor: 17.367

2.  -94 ATTG insertion/deletion polymorphism of the NFKB1 gene is associated with coronary artery disease in Han and Uygur women in China.

Authors:  Yi-Ning Yang; Jin-Yu Zhang; Yi-Tong Ma; Xiang Xie; Xiao-Mei Li; Fen Liu; Bang-Dang Chen; Xing-Hui Dong; Ying-Ying Zheng; Shuo Pan; Hui Zhai; Dong-Ze Li; Qing-Jie Chen
Journal:  Genet Test Mol Biomarkers       Date:  2014-05-12

3.  Cardiac-specific suppression of NF-κB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system.

Authors:  Candice M Thomas; Qian Chen Yong; Rodolfo M Rosa; Rachid Seqqat; Shanthi Gopal; Dulce E Casarini; W Keith Jones; Sudhiranjan Gupta; Kenneth M Baker; Rajesh Kumar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-01       Impact factor: 4.733

4.  Diacerein improves left ventricular remodeling and cardiac function by reducing the inflammatory response after myocardial infarction.

Authors:  Anali Galluce Torina; Karla Reichert; Fany Lima; Karlos Alexandre de Souza Vilarinho; Pedro Paulo Martins de Oliveira; Helison Rafael Pereira do Carmo; Daniela Diógenes de Carvalho; Mário José Abdalla Saad; Andrei Carvalho Sposito; Orlando Petrucci
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

5.  Overexpression of IκBα in cardiomyocytes alleviates hydrogen peroxide-induced apoptosis and autophagy by inhibiting NF-κB activation.

Authors:  Min Han; Xiao-Cui Chen; Ming-Hui Sun; Min-Tao Gai; Yi-Ning Yang; Xiao-Ming Gao; Xiang Ma; Bang-Dang Chen; Yi-Tong Ma
Journal:  Lipids Health Dis       Date:  2020-06-24       Impact factor: 3.876

6.  Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes.

Authors:  Meng Wu; Yeping Yang; Meng Wang; Fangfang Zeng; Qin Li; Wenjuan Liu; Shizhe Guo; Min He; Yi Wang; Jie Huang; Linuo Zhou; Yiming Li; Ji Hu; Wei Gong; Zhaoyun Zhang
Journal:  Front Pharmacol       Date:  2018-08-07       Impact factor: 5.810

7.  Enhancement of cellular antioxidant-defence preserves diastolic dysfunction via regulation of both diastolic Zn2+ and Ca2+ and prevention of RyR2-leak in hyperglycemic cardiomyocytes.

Authors:  Erkan Tuncay; Esma N Okatan; Aysegul Toy; Belma Turan
Journal:  Oxid Med Cell Longev       Date:  2014-02-13       Impact factor: 6.543

8.  Activin A inhibition attenuates sympathetic neural remodeling following myocardial infarction in rats.

Authors:  Juan Hu; Xi Wang; Yan-Hong Tang; Ying-Guang Shan; Qiang Zou; Zhi-Qiang Wang; Cong-Xin Huang
Journal:  Mol Med Rep       Date:  2018-01-25       Impact factor: 2.952

9.  Cardiomyocyte-Specific Snrk Prevents Inflammation in the Heart.

Authors:  Karthikeyan Thirugnanam; Stephanie M Cossette; Qiulun Lu; Shreya R Chowdhury; Leanne M Harmann; Ankan Gupta; Andrew D Spearman; Dmitry L Sonin; Michelle Bordas; Suresh N Kumar; Amy Y Pan; Pippa M Simpson; Jennifer L Strande; Erin Bishop; Ming-Hui Zou; Ramani Ramchandran
Journal:  J Am Heart Assoc       Date:  2019-11-13       Impact factor: 5.501

10.  The protective effects of S14G-humanin (HNG) against streptozotocin (STZ)-induced cardiac dysfunction.

Authors:  Xiaopan Chen; Chuan Yun; Hailong Zheng; Xu Chen; Qianfei Han; Hua Pan; Yang Wang; Jianghua Zhong
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.